Medpace Holdings Inc

MEDP: XNAS (USA)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
x>pLOCK|#?c!!LOCK|r&?^dj

Medpace Earnings: Despite Strong Revenue, Elevated Cancellations Worry Investors; Shares Tank 16%

Medpace reported fourth-quarter revenue of $708.5 million, growing 32% over the prior-year period. However, elevated cancellations resulted in a net book/bill ratio of 1.04 times in the quarter, down sequentially from 1.20 in the third quarter. The stock dropped 16% on Feb. 10.

Sponsor Center